Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Michael Jerome Whalen, M.D.

Co-Author

This page shows the publications co-authored by Michael Whalen and Eng Lo.
Connection Strength

3.565
  1. Repetitive Mild Closed Head Injury in Adolescent Mice Is Associated with Impaired Proteostasis, Neuroinflammation, and Tauopathy. J Neurosci. 2022 Mar 23; 42(12):2418-2432.
    View in: PubMed
    Score: 0.246
  2. Genetic inhibition of RIPK3 ameliorates functional outcome in controlled cortical impact independent of necroptosis. Cell Death Dis. 2021 11 09; 12(11):1064.
    View in: PubMed
    Score: 0.242
  3. Cell-specific activation of RIPK1 and MLKL after intracerebral hemorrhage in mice. J Cereb Blood Flow Metab. 2021 07; 41(7):1623-1633.
    View in: PubMed
    Score: 0.226
  4. Interleukin-1 Receptor 1 Deletion in Focal and Diffuse Experimental Traumatic Brain Injury in Mice. J Neurotrauma. 2019 01 15; 36(2):370-379.
    View in: PubMed
    Score: 0.193
  5. Repetitive head injury in adolescent mice: A role for vascular inflammation. J Cereb Blood Flow Metab. 2019 11; 39(11):2196-2209.
    View in: PubMed
    Score: 0.192
  6. Genetic Inhibition of Receptor Interacting Protein Kinase-1 Reduces Cell Death and Improves Functional Outcome After Intracerebral Hemorrhage in Mice. Stroke. 2017 09; 48(9):2549-2556.
    View in: PubMed
    Score: 0.180
  7. Dual effects of carbon monoxide on pericytes and neurogenesis in traumatic brain injury. Nat Med. 2016 11; 22(11):1335-1341.
    View in: PubMed
    Score: 0.170
  8. Role of Akt and mammalian target of rapamycin in functional outcome after concussive brain injury in mice. J Cereb Blood Flow Metab. 2014 Sep; 34(9):1531-9.
    View in: PubMed
    Score: 0.145
  9. The pharmacokinetics and pharmacodynamics of Kollidon VA64 dissociate its protective effects from membrane resealing after controlled cortical impact in mice. J Cereb Blood Flow Metab. 2014 Aug; 34(8):1347-53.
    View in: PubMed
    Score: 0.144
  10. Akt and mTOR mediate programmed necrosis in neurons. Cell Death Dis. 2014 Feb 27; 5:e1084.
    View in: PubMed
    Score: 0.142
  11. Concussive injury before or after controlled cortical impact exacerbates histopathology and functional outcome in a mixed traumatic brain injury model in mice. J Neurotrauma. 2013 Mar 01; 30(5):382-91.
    View in: PubMed
    Score: 0.132
  12. Neuregulin-1 effects on endothelial and blood-brain-barrier permeability after experimental injury. Transl Stroke Res. 2012 Jul; 3 Suppl 1:S119-24.
    View in: PubMed
    Score: 0.125
  13. Traumatic brain injury during warfarin anticoagulation: an experimental study in mice. J Neurotrauma. 2012 Apr 10; 29(6):1150-5.
    View in: PubMed
    Score: 0.124
  14. Neurovascular matrix metalloproteinases and the blood-brain barrier. Curr Pharm Des. 2012; 18(25):3645-8.
    View in: PubMed
    Score: 0.122
  15. Kollidon VA64, a membrane-resealing agent, reduces histopathology and improves functional outcome after controlled cortical impact in mice. J Cereb Blood Flow Metab. 2012 Mar; 32(3):515-24.
    View in: PubMed
    Score: 0.121
  16. Plasmalemma permeability and necrotic cell death phenotypes after intracerebral hemorrhage in mice. Stroke. 2012 Feb; 43(2):524-31.
    View in: PubMed
    Score: 0.121
  17. Combination therapy targeting Akt and mammalian target of rapamycin improves functional outcome after controlled cortical impact in mice. J Cereb Blood Flow Metab. 2012 Feb; 32(2):330-40.
    View in: PubMed
    Score: 0.120
  18. Tumor necrosis factor alpha and Fas receptor contribute to cognitive deficits independent of cell death after concussive traumatic brain injury in mice. J Cereb Blood Flow Metab. 2011 Feb; 31(2):778-89.
    View in: PubMed
    Score: 0.112
  19. Genetic analysis of the role of tumor necrosis factor receptors in functional outcome after traumatic brain injury in mice. J Neurotrauma. 2010 Jun; 27(6):1037-46.
    View in: PubMed
    Score: 0.110
  20. Effect of neuregulin-1 on histopathological and functional outcome after controlled cortical impact in mice. J Neurotrauma. 2007 Dec; 24(12):1817-22.
    View in: PubMed
    Score: 0.092
  21. Acute plasmalemma permeability and protracted clearance of injured cells after controlled cortical impact in mice. J Cereb Blood Flow Metab. 2008 Mar; 28(3):490-505.
    View in: PubMed
    Score: 0.090
  22. Cell-cell signaling in the neurovascular unit. Neurochem Res. 2007 Dec; 32(12):2032-45.
    View in: PubMed
    Score: 0.088
  23. TNF alpha and Fas mediate tissue damage and functional outcome after traumatic brain injury in mice. J Cereb Blood Flow Metab. 2007 Nov; 27(11):1806-18.
    View in: PubMed
    Score: 0.088
  24. Thrombospondin-1 Gene Deficiency Worsens the Neurological Outcomes of Traumatic Brain Injury in Mice. Int J Med Sci. 2017; 14(10):927-936.
    View in: PubMed
    Score: 0.045
  25. FGF21 Attenuates High-Fat Diet-Induced Cognitive Impairment via Metabolic Regulation and Anti-inflammation of Obese Mice. Mol Neurobiol. 2018 Jun; 55(6):4702-4717.
    View in: PubMed
    Score: 0.045
  26. CD47 deficiency improves neurological outcomes of traumatic brain injury in mice. Neurosci Lett. 2017 03 16; 643:125-130.
    View in: PubMed
    Score: 0.043
  27. Targeting the neurovascular unit in brain trauma. CNS Neurosci Ther. 2015 Apr; 21(4):304-8.
    View in: PubMed
    Score: 0.037
  28. Translational insights into traumatic brain injury occurring during dabigatran or warfarin anticoagulation. J Cereb Blood Flow Metab. 2014 May; 34(5):870-5.
    View in: PubMed
    Score: 0.035
  29. Neuroglobin-overexpression reduces traumatic brain lesion size in mice. BMC Neurosci. 2012 Jun 15; 13:67.
    View in: PubMed
    Score: 0.032
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.